期刊文献+

初诊2型糖尿病患者CD4^+CD25^+FoxP3^+调节性T细胞的变化和意义 被引量:9

Change and significance of CD4^+CD25^+FoxP3^+Treg in patients with type 2 diabetes before and after insulin intensive therapy
原文传递
导出
摘要 目的探讨CD4+CD25+FoxP3+调节性T细胞(Treg细胞)在2型糖尿病(T2DM)发生、发展中的作用。方法应用细胞膜打孔和三色荧光标记流式细胞术检测46例初诊T2DM患者胰岛素强化治疗前后的CD4+CD25+FoxP3+Treg细胞的比例,并分析其与细胞因子的相关性。结果胰岛素强化治疗3个月后,CD4+CD25+FoxP3+Treg细胞的比例和CD3+T、CD4+T细胞均较治疗前明显升高,C反应蛋白(C-RP)和肿瘤坏死因子α(TNF-α)水平较治疗前降低(P<0.05)。治疗前后CD4+CD25+FoxP3+Treg细胞的比例与CD3+、CD4+、TNF-α、白细胞介素6(IL-6)、胰岛素抵抗指数(HOMA-IR)、胰岛细胞功能指数(HOMA-β)均无明显相关性。治疗前,CD3+T细胞百分比与CD4+T细胞百分比、IL-6水平与HOMA-β成正相关(P<0.05)。治疗2周时,TNF-α与HOMA-IR和HOMA-β成正相关,而IL-6与C-RP成负相关(P<0.05)。结论初诊T2DM患者存在CD4+CD25+FoxP3+Treg细胞数量的紊乱,胰岛素强化治疗后CD4+CD25+FoxP3+Treg细胞较治疗前显著升高。低水平的Treg细胞一方面可能是T2DM发生发展的因素,另一方面可能是高血糖的结果 。 Objective To study the proportion of CD4^+CD25^+FoxP3^+ regulatory T cell in patients with type 2 diabetes(T2DM) before and after insulin intensive therapy.Methods The propotion of CD4^+CD25^+FoxP3^+ regulatory T cells was measured with flow cytometry in 46 T2DM cases before and after insulin intensive therapy and the relationship between that and other cytokines was analyzed.Results The propotion of CD4^+CD25^+FoxP3^+ regulatory T cell and the amonts of CD3+T and CD4+T cells were significantly higher after treatment than those before(P0.05).The levels of C-reactive protein(C-RP) and tumor necrosis factor-α(TNF-α) were significantly lower after treatment than those before(P0.05).The proportion of CD4^+CD25^+FoxP3^+ regulatory T cells was not significantly correlated with CD3+,CD4+,TNF-α,IL-6,HOMA-IR and HOMA-β.After 2 weeks of insulin treatment,the level of TNF-α was positively correlated with both HOMA-IR and HOMA-β(P0.05),while IL-6 negatively correlated with C-RP(P0.05).Conclusion The proportion of CD4^+CD25^+FoxP3^+ regulatory T cells is increased in T2DM patients after insulin intensive therapy.Reduced level of Treg cells may be the result of hyperglycemia and a factor for the development and progress of T2DM as well.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第9期996-999,I0001,共5页 Jiangsu Medical Journal
基金 连云港市卫生局科技发展项目(07006)
关键词 2型糖尿病 调节性T淋巴细胞 胰岛素抵抗 Type 2 diabetes mellitus Regulatory T cell Insulin resistance
  • 相关文献

参考文献16

  • 1PickupJC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes[J].Diabetes Care, 2004, 27 (3) :813-823.
  • 2Donath MY,Storling J,Maedler K, et al. Inflammation mediators and islet beta-cell failure:a link between typel and type 2 diabetes[J]. J Mol Med,2003,81(8):455 470.
  • 3Kukreja A,Cost G,Marker J, et al. Multiple immuno-regulatory defects in type-1 diabetes [J].J Clin Invest, 2002, 109(1):131-140.
  • 4Brusko TM, Wasserfall CH, Clare-Salzler MJ, et al. Func tional defects and the influence of age on the freguency of CD4+CD25+ T cells in type 1 Diabetes[J].Diabetes, 2005, 54(5) : 1407-1414.
  • 5杨治芳,周智广,唐炜立,黄干,彭健,李霞,何凌.成人隐匿性自身免疫糖尿病CD4^+调节性T细胞研究[J].中华医学杂志,2006,86(36):2533-2536. 被引量:7
  • 6Sakaguchi S,Sakaguchi N,Asano M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases [J].J Immunol, 1995,155(3): 1151- 1164.
  • 7Hori S,Nomura T,Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [J]. Science, 2003,299(5609) : 1057-1061.
  • 8Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers[J].Nat Rev Immunol, 2002, 2 (6) : 389- 400.
  • 9Bach JF. Regulatory T cells under scrutiny[J]. Nat Rev Immunol, 2003,3(3) :189 -198.
  • 10Bluestone JA,Abbas AK. Natural versus adaptive regulatory T cells[J].Nat Rev Immunol,2003,3(3):253- 257.

二级参考文献20

  • 1任瑞珍,陈国瑞,蔡俊峰,陶耕,李永加.肿瘤坏死因子α基因多态性与2型糖尿病胰岛素抵抗的相关性[J].中华内分泌代谢杂志,2003,19(4):271-274. 被引量:14
  • 2何凌,周智广,罗建华,杨琳,陈小燕,王建平,李莉蓉,邓志明,苏恒.成人隐匿性自身免疫性糖尿病患者CD_4^+CD_(25)^+ T细胞亚群的变化[J].中华糖尿病杂志(1006-6187),2005,13(6):428-431. 被引量:12
  • 3王弋,许国根,吴锦鸿,赵雪,缪群,陈雯.全身炎症反应综合征患者胰岛素强化治疗对血清炎症介质的影响[J].全科医学临床与教育,2007,5(1):36-38. 被引量:4
  • 4Das UN. Is insulin an antiinflammation molecule. Nutrition, 2001, 17 : 409-413.
  • 5Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest,2005,115:2277-2286.
  • 6Khattri R,Cox T,Yasayko SA,et al.An essential role for Scurfin in CD4^+ CD25^+ T regulatory cells.Nat Immunol,2003,4:337-342.
  • 7Roncador G,Brown PJ,Maestre L,et al.Analysis of FOXP3 protein expression in human CD4^+ CD25^+ regulatory T cells at the single-cell level.Eur J Immunol,2005,35:1681-1691.
  • 8Lindley S,Dayan CM,Bishop A,et al.Defective suppressor function in CD4 (+) CD25 (+) T-cells from patients with type 1diabetes.Diabetes,2005,54:92-99.
  • 9Brusko TM,Wasserfall CH,Clare-Salzler MJ,et al.Functional defects and the influence of age on the frequency of CD4^+ CD25^+ T-cells in type 1 diabetes.Diabetes,2005,54:1407-1414.
  • 10Denise F,George EJ,John D,et al.abnormal T-lymphocyte subsets in type 1 diabetes.Diabetes,1989,38:1462-1468.

共引文献7

同被引文献135

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部